MX9705324A - Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas. - Google Patents

Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas.

Info

Publication number
MX9705324A
MX9705324A MX9705324A MX9705324A MX9705324A MX 9705324 A MX9705324 A MX 9705324A MX 9705324 A MX9705324 A MX 9705324A MX 9705324 A MX9705324 A MX 9705324A MX 9705324 A MX9705324 A MX 9705324A
Authority
MX
Mexico
Prior art keywords
methyl
pyrrolidenyl
isoxazole
dispensing
pharmaceutically acceptable
Prior art date
Application number
MX9705324A
Other languages
English (en)
Other versions
MXPA97005324A (es
Inventor
Hanshermann Franke
Gerd Hoffmann
Heinrich Kindel
Stephen Peter Arneric
James Patrick Sullivan
John Burns Cannon
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9705324A publication Critical patent/MX9705324A/es
Publication of MXPA97005324A publication Critical patent/MXPA97005324A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings

Abstract

Una forma de aplicacion para el sustrato de (s)-3-mietl-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas está caracterizada en que es un sistema terapéutico transdermal que tiene la forma de un emplasto.
MXPA/A/1997/005324A 1995-01-14 1997-07-14 Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas MXPA97005324A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19501022.1 1995-01-14
DE19501022A DE19501022C1 (de) 1995-01-14 1995-01-14 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
PCT/EP1996/000074 WO1996021434A1 (de) 1995-01-14 1996-01-10 Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze

Publications (2)

Publication Number Publication Date
MX9705324A true MX9705324A (es) 1997-10-31
MXPA97005324A MXPA97005324A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ATE292458T1 (de) 2005-04-15
BR9607488A (pt) 1997-12-23
CA2210341A1 (en) 1996-07-18
ZA96260B (en) 1996-08-01
KR19980701419A (ko) 1998-05-15
WO1996021434A1 (de) 1996-07-18
EP0802790A1 (de) 1997-10-29
DE19501022C1 (de) 1996-06-05
DE59611212D1 (de) 2005-05-12
IL116615A (en) 1999-09-22
IL116615A0 (en) 1996-03-31
AR001070A1 (es) 1997-09-24
EP0802790B1 (de) 2005-04-06
JPH10511972A (ja) 1998-11-17
NZ298428A (en) 1999-10-28

Similar Documents

Publication Publication Date Title
GB2303064B (en) Medicament for nasal administration
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
ZA962536B (en) Pharmaceutical composition for transdermal administration.
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
AU4399196A (en) Intravaginal drug delivery devices for the administration of 17beta -oestradiol precursors
WO1998006380A3 (en) Dosage form for providing ascending dose of drug
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
GB9601969D0 (en) A system for the delivery of drugs and therapeutic agents
NO952906L (no) Farmasöytisk formulering for behandling av nikotinavhengighet
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
IL116539A0 (en) Compositions for transdermal delivery of acid-labile drugs
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
GEP20043157B (en) Medicament Against Migraine Recurrence
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
CY2388B1 (en) Rate-controlled transdermal administration of risperidone.
ZA96260B (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
AU4391196A (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances
GB9218422D0 (en) Device for administering single doses of medicament
MX9710002A (es) Nuevo uso medico.
IL137496A0 (en) Dosage form and pharmaceutical kit for increasing the oral availablity of pharmaceutical agents
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
AUPN699395A0 (en) Patient controlled drug delivery device
AU5887796A (en) Patient controlled drug delivery device

Legal Events

Date Code Title Description
FA Abandonment or withdrawal